269 results
Page 12 of 14
8-K
EX-99.1
q1fso
6 Apr 11
BioTime and XenneX Form LifeMap Sciences, Inc. to Create Roadmap for Regenerative Medicine
12:00am
8-K
EX-99.1
7dbp8e
22 Mar 11
BioTime Announces the Closing of the Merger of Glycosan BioSystems with OrthoCyte Corporation
12:00am
8-K
w5d9 rqewg1wrwjaglmx
22 Mar 11
BioTime Announces the Closing of the Merger of Glycosan BioSystems with OrthoCyte Corporation
12:00am
8-K
EX-99.1
jaam35x8q7qgs0
15 Mar 11
BioTime Announces Fourth Quarter and Fiscal Year 2010 Financial Results and Corporate Developments
12:00am
8-K
EX-99.1
curz5bp
4 Mar 11
Update on ReCyte™ technology for resetting telomere length and its application in cardiovascular disease
12:00am
8-K
EX-99.1
6bl5ynh8wljuehtp5
14 Feb 11
BioTime Announces Agreement To Acquire Glycosan BioSystems
12:00am
8-K
jrpwfk qvh
14 Feb 11
BioTime Announces Agreement To Acquire Glycosan BioSystems
12:00am
8-K
EX-99.1
3kmytjb qoi
28 Jan 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-99.1
7u46ktde91cgp2q7d
10 Jan 11
BioTime’s CEO Michael West to Present Preclinical Data on OTX-CP03 and OTX-CP07 for the Treatment of Osteoarthritis at STEM 2011 in Gurgaon, India
12:00am
CORRESP
p0tp 6flst7xy
4 Jan 11
Correspondence with SEC
12:00am
8-K
EX-99.1
q0n5lu3e4
3 Jan 11
BioTime Subsidiary ReCyte Therapeutics, Inc. to Develop Therapies for Age-Related Cardiovascular and Blood Disorders
12:00am
8-K
EX-99.1
nb3 96x79uvmhe1
9 Dec 10
BioTime Asia, Limited and Shanghai Genext Medical Technology Co., Ltd. Sign Marketing Agreement for ACTCellerate™ Cell Lines
12:00am
8-K
ul8ioxooees558
9 Dec 10
BioTime Asia, Limited and Shanghai Genext Medical Technology Co., Ltd. Sign Marketing Agreement for ACTCellerate™ Cell Lines
12:00am
8-K
sa30los
10 Nov 10
Other Events
12:00am
8-K
EX-99.1
agiwezii
10 Nov 10
Other Events
12:00am